Multislice computer tomography (MSCT) for the optimisation of transcatheter aortic valve implantation (TAVI) and 3-D TEE can evaluate all anatomical aspects of the aortic root. (6) (7) (8) MSCT is particularly attractive for the evaluation of anatomy because it provides the user with a 3-D virtual representation that can be viewed from any angle or cut-plane after acquisition. What follows is a review of the role of MSCT pre-and post-TAVI.
INTRODUCTION
Severe symptomatic aortic stenosis is found in 1% of patients aged 65 to 75 and 5% of patients aged over 75 years.
(1) Surgical aortic valve replacement (SAVR) is a life saving treatment, but for the approximately one third of patients who are ineligible for SAVR the prognosis is poor with <50% survival within 1 year. (2, 3) Transcatheter aortic valve implantation (TAVI) is a new treatment option for patients who are not eligible for surgery due to high levels of co-morbidity. In this patient group the multicentre randomised PARTNER trial demonstrated that TAVI improved prognosis and quality of life when compared to medical therapy. (3) In contrast to open surgery, which proceeds under direct vision, TAVI relies on imaging. Pre-procedural imaging is used to: Select patients who are anatomically suitable for TAVI; determine the vascular access route; size (sizing helps match prosthesis size to patient anatomy); guide the implantation procedure; and to evaluate the result. In the majority of procedures where patients received a TAVI prosthesis thus far contrast angiography (CA) and 2-D echocardiography -either transthoracic (TTE) or transoesophageal (TEE) -were used to execute all these steps. (4, 5) However, the Summer 2012 Volume 9 • Number 1 Interestingly the majority of studies that examined the diagnostic accuracy of MSCT planimetry for the diagnosis of severe aortic stenosis used as comparator TTE AVA based on the continuity equation. (11) This can be viewed as a limitation given that the gold standard for the diagnosis of aortic stenosis in patients with preserved left ventricular function is peak transvalvular flow velocity from TTE. There are also technical limitations with measuring AVA by planimetry including obtaining a true short axis viewing plane when using TEE and signal loss caused by calcium.
Ultimately it is the physiological limitation in flow that causes symptoms and reduces prognosis in aortic stenosis so that diagnostic parameters incorporating flow have a fundamental advantage over AVA planimetry, which is purely anatomical.
A proof of concept study recently described a technique for measuring transaortic peak flow velocity on MSCT. (17) The diagnostic accuracy of AVA and indexed AVA from MSCT planimetry was found to be moderate when compared to a gold standard of transvalvular peak flow obtained with TTE. MSCT derived peak flow velocity and showed a better sensitivity and specificity (respectively 100% and 76%) for the diagnosis of severe aortic stenosis than did aortic valve area (respectively 74% and 76%) or indexed aortic valve area (respectively 74% and 65% (19) In the testing cohort an AVC threshold of >1651 Agatston units, when compared to a gold standard of dobutamine stress echocardiography, had a sensitivity of 95% and a specificity of 89% for the detection of severe aortic stenosis. The authors concluded that AVC measured on MSCT may help to identify patients with a low ejection fraction who may benefit from TAVI or SAVR.
ELIGIBILITY
Pre-procedural imaging is used to evaluate the suitability of the aortic root for the deployment and secure lodgement of one of the TAVI prosthesis types and sizes as well as the feasibility of transcatheter delivery of the prosthesis (Figure 1 ). There are 2 commercially available prostheses namely the Edwards SAPIEN balloon expandable device (ESD) and the Medtronic Corevalve self-expanding device (MCS) (Figure 2, 3) . The design and deployment features have been extensively described. (4, 5, 20) Potential candidates for TAVI are screened based on anatomical eligibility guidelines, which are device-specific due to the differences in the design and geometry between the MCS and ESD (Figure 1 ).
The eligibility guidelines provided by industry have recently been summarised. (21) Aortic root dimensions 
Sizing
The aortic annulus or basal plane is defined anatomically as the virtual ring with 3 anchor points at the nadirs of the 3 leaflets of the crown shaped aortic valve (22, 23) ( respectively meant for annuli of 18-21mm and 22-24mm and a 29mm device, which can be delivered only via the transapical route, designed for annuli of 25-29mm. The differences in size between the ESD and the MCS means that the majority of patients will be eligible for one of the two prostheses types. (24) Although the sizing guidelines are straightforward the measurement of the aortic annulus diameter by non-invasive imaging is not as simple as might be implied. Studies using 3-D imaging modalities including MSCT, CMRI and 3-D TTE/TEE have shown that the aortic annulus is not round but oval in shape (10, 12, 13, 25) (Figure 3 ). In one study using MSCT to evaluate the aortic root in 75 patients who were candidates for TAVI an oval annulus was seen in approximately 78% of patients. (26) By implication a minimum and maximum diameter could be measured and the difference between the 2 was on average 6.5mm (95% confidence interval 5.7-7.2). The TTE parasternal long axis view and TEE 3-chamber, both of which are routinely used for sizing, allow only measurement of an oblique sagittal diameter, which approximates the minimum diameter of the aortic annulus. (27) The coronal, which approximates the maximum diameter, cannot be measured on TTE/TEE (6, 28) (Figure 3 ).
The mean annulus diameters derived from any of the arithmetic mean, perimeter or area barely differ from each other and fall in between the minimum and maximum. (26) The annulus diameter measured a TTE PLAX view or TEE 3 chamber view falls in between the mean and the minimum diameter, and the coronal diameter from contrast aortography falls in between the mean and maximum diameters. (27, 28) The differences between the imaging modalities represent anatomically different dimensions of a complex structure rather than discrepancies, (Figure 3 ), whereas a lesser contribution may be expected from measurement variability and -method. Figure 3 shows how these measurements relate to one another based on an axial image of the aortic annulus. The use of the different diameter measurements has substantial implications for the selection of prosthesis size. One study examined sizing for the ESD by either MSCT or TTE and TEE in 45 patients. (27) If sizing were based on MSCT mean diameter 38% of patients would not have been eligible for an ESD (due to the annulus being too large) whereas respectively 24% and 33% were ineligible based on TTE and TEE. The authors concluded, based on the results of their current practice, that sizing should be based on TTE/TEE. Another study examining the hypothetical effects of sizing for the
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MCS by different MSCT diameter measurements in 75 patients
reported that 26% to 39% of patients would not be eligible for a MCS if sizing were based on the minimum and maximum diameters (26) patients also reported that the post-implantation cross-sectional area achieved at the inflow of the MCS frame was most similar to the mean diameter and the CSA of the native annulus preimplantation. (30) Despite these interesting observations there are no randomised data on which approach to sizing gives the best
outcome. An important point is that the recent availability of more prosthesis sizes increases the proportion of eligible patients but also the potential adverse effects of a sizing error. Data that suggest an effect of sizing on outcome, but not which sizing strategy to use, is discussed in a later section.
FIGURE 2: Sizing for TAVI is based on the dimensions of the aortic annulus
Sizing for both Edwards SAPIEN (A) and Medtronic CoreValve (D) devices is based on the "diameter" of the aortic annulus. Anatomically the aortic valve is crown-shaped (B) and the aortic annulus is not an anatomical entity but rather a virtual ring with 3 anchor points at the nadirs of the 3 aortic leafl ets (green line, C). On angiography the level of the aortic annulus can be localised before (E) and after (F) TAVI. The inset (G) shows on a short-axis view from MSCT that the aortic annulus is usually oval-shaped so that more than one diameter measurement is required to describe its dimensions. 
Vascular access
Multiple studies have shown that MSCT is an excellent diagnostic tool for the detection of significant stenosis in the peripheral vasculature. (32) MSCT is increasingly being used for the more demanding role of screening vascular access routes for TAVI. (33, 34) The advantage is that an overview of all potential vascular access routes, including transfemoral, -subclavian or -apical may be obtained, (35) (Figure 4) . In a combined scanning protocol the vascular overview can be obtained immediately following a scan of the heart without requiring additional contrast.
With modern scanning techniques, such as prospective ECG synchronised high pitch (flash), only an incremental increase in radiation dose is required above that of the heart scan. (35) In addition to information on vascular luminal diameter MSCT provides a detailed overview of the 3 dimensional tortuosity and calcification of the vascular tree. All 3 these factors have to be considered when choosing the access route in order to deduce permissibility for the
FIGURE 3: MSCT facilitates understanding of which dimensions of the aortic annulus may be measured with different imaging modalities
The left column shows an oblique sagittal view on MSCT (top) corresponding to the parasternal long axis view on transthoracic-and the 3 chamber view on transoesophageal echocardiography (bottom). The right column shows an oblique coronal view on MSCT (top) corresponding to an anteroposterior type view on contrast angiography (bottom). On a short-axis view of the aortic annulus (inset, middle column) the diameter measurements obtained from echocardiography (green) and angiography (yellow) are indicated as well as the true minimum and maximum dimensions (blue), which are not readily appreciable on echocardiography or angiography in approximately one third of patients.
relatively rigid undeployed TAVI prostheses, (34, 31) (Figure 4 
PROCEDURAL GUIDANCE
Contrast angiography (CA) is likely to remain the standard imaging technique for guidance for the foreseeable future. Two aspects that may improve procedural guidance include the use of the optimal projection (OP) and new developments in software aimed at facilitating positioning during device deployment.
Optimal projection
The OP is defined as the C-arm angulation that will show the 3 aortic sinuses aligned on one plane and separated so that all 3 sinuses are clearly distinguishable. The optimal projection can be obtained from pre-procedural MSCT. (36, 37, 38) In brief this is done by first setting up a short-axis plane of the aortic annulus, then parallel shifting it to the level of the coaptation of the aortic leaflets. 
HOW TO INTERROGATE AN MSCT PRE-TAVI
A step-by-step method for defining the aortic annulus on MSCT and the different measurements has been described using a conventional MSCT workstation as well as dedicated TAVI-planning software that reduces the amount of user input required and speeds up the analysis process.
EVALUATION
After device release the depth of implantation, frame expansion and degree of aortic regurgitation are of interest. MSCT allows a detailed evaluation of frame expansion, asymmetry and apposition to surrounding tissue on short axis images ( Figure 7 ). This applies to both the ESD and the MCS. Planning for a transapical approach shows the optimal rib space and direction of puncture (top row). In patients with no other options direct aortic access via a mini-thoracotomy has been described and the potential catheter path can be planned with MSCT (bottom row).
too deep position of the implanted prosthesis, implantation of a second prosthesis (valve-in-valve). Residual paravalvular aortic regurgitation of a mild or more severe degree is common after TAVI occurring in between 15 and 50% of cases. (44,45,46,47.48) Although mild to moderate PAR after SAVR is not thought to adversely affect haemodynamics a recent retrospective multicentre registry found an association of mild to moderate PAR (defined as ≥2/4) with increased mortality in TAVI patients. (46) The data suggested that residual PAR is a marker of an adverse risk profile and it is not clear whether reducing the degree of PAR may also reduce risk of adverse events in the present TAVI population.
The intention of industry guidelines for prosthesis size selection is for some degree of over-sizing to ensure a reasonable force of apposition of the sealing skirt to the surrounding tissue in order to ameliorate PAR and ensure positional stability. Imaging studies of the aortic root using either TTE or MSCT have found that residual PAR was associated with larger aortic annulus dimensions and a lower ratio of nominal prosthesis to annulus diameter, indicating that a lesser degree of over-sizing may be associated with PAR. (44, 45, 49, 50) In these studies there was substantial overlap in the prosthesis to annulus ratio between patients with and without mild to moderate PAR, indicating that other factors also play a role. A small study of 54 patients localised the jets of PAR around the MCS prosthesis inflow in relation to the native anatomy and found that PAR was most common on the inside curve of the aortic arch, which is also the left side of the largest diameter of the aortic annulus, and at the aorta-mitral fibrous continuity. (45) In the same study MSCT post-TAVI demonstrated that mal-apposition of the device frame to the surrounding tissue was also more frequent at these two anatomical locations. The authors concluded that the angulation of the aorta in addition to sizing and calcification may contribute to the etiology of PAR after TAVI with an MCS. (45) In other studies mild to moderate PAR was also associated with a higher degree of calcification of the aortic root. (39, 50) In patients with a more than moderate degree of PAR immediately after TAVI, balloon post-dilatation is usually the first step to reduce it.
A case series of 100 patients who received a MCS and where postdilatation was performed in 30% quantified the degree of aortic root calcification on pre-procedural MSCT. In that study an aortic root Agatston score >3 000 associated with post-dilatation and was positively correlated with the final degree of regurgitation. (39) Another study of 110 patients who received the MCS and where post-dilatation was performed in 11 cases found that the need for balloon post-dilatation was associated with larger annulus diameter, a lower ratio of prosthesis to annulus size and the degree of calcification of the aortic root or leaflets. (51) In that study the ability to discriminate the need for balloon post-dilatation was poor for the prosthesis to annulus ratio (area under a ROC curve 0.3), moderate for annulus dimensions (area under ROC curve 0.67) and excellent for calcification (area under ROC curve >0.8). (51) These data indicate that calcification is the most-important determinant of significant PAR and the need for post-dilatation and may, in future, lead to the testing of new procedural strategies intended to reduce PAR in patients known to have very dense aortic root calcification.
Device dislodgement
Late (post-implantation procedure) dislodgement of the TAVI prosthesis is rare. In one case report it was thought to be related to low levels of calcification of the aortic leaflets, poor left ventricular function and possibly to undersizing. (52) Predictors of intraprocedural device dislodgement, which required device retrieval and repeated implantation in the correct position, were investigated in one study of 98 patients. (53) Device dislodgement occurred in 18 of the patients and was associated with larger aortic valve area and a lower degree of aortic root calcification. In multivariate analysis an aortic root calcium threshold of <2 359 (Agatston score) was the only independent predictor for valve dislodgement (OR 3.1, 95% confidence interval 1.1 -8.8). The authors proposed that, in patients with low levels of aortic root calcification device deployment during rapid pacing may be considered to avoid dislodgement during the deployment stage. (53) New conduction abnormalities or pacing requirement
New conduction abnormalities requiring implantation of a permanent pacemaker are higher after TAVI than after SAVR. The rate of implantation of permanent pacemakers in patients with a MCS ranges from 9 to 39%. (54) (55) (56) Anatomical factors identified on MSCT that were associated with pacemaker requirement include a higher prosthesis to annulus ratio and a higher pre-dilatation balloon to annulus ratio. (55, 57) Whether aortic root calcification is associated with pacemaker requirement is controversial. (58, 59) Iatrogenic membranous VSD Iatrogenic membranous VSD is uncommon after TAVI but may have adverse consequences. (41, 60) A case report described the occurrence of iatrogenic VSD following post-dilatation of the TAVI prosthesis with a relatively oversized balloon in a patient with an unusually long ventricular membranous septum. The unusual anatomic finding of a long ventricular extent of the membranous septum was readily discernable on pre-implantation MSCT in a small series of patients. (41) CONCLUSIONS:
THE EVOLVING ROLE OF IMAGING
The use of MSCT for planning TAVI has improved our understanding of the role and limitations of commonly used 2-D imaging modalities including CA and TTE/TEE and is contributing to a more detailed understanding of anatomical factors, identifiable on preprocedural imaging that may impact on procedural outcome.
Most of these observations come from case series and as such the data need to be confirmed. However, a detailed understanding of patient anatomy obtained from MSCT will increasingly lead to a tailored patient-specific approach to optimise the outcome of TAVI.
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